ID   HML/SE
AC   CVCL_RL98
DR   Wikidata; Q54889938
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9642254;
CC   Population: Japanese.
CC   Characteristics: CSF2 and KITLG dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL96 ! HML
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=9642254; DOI=10.1074/jbc.273.27.16921;
RA   Sato, Takeshi
RA   Watanabe, Sumiko
RA   Ishii, Eizaburo
RA   Tsuji, Kohichiro
RA   Nakahata, Tatsutoshi
RT   "Induction of the erythropoietin receptor gene and acquisition of
RT   responsiveness to erythropoietin by stem cell factor in HML/SE, a
RT   human leukemic cell line.";
RL   J. Biol. Chem. 273:16921-16926(1998).
//